Antipsychotics Prescribing Patterns of Patients with Schizophrenia Admitted to Korean General Hospital Psychiatric Unit: 2001 to 2008

키워드

참고문헌 (30)

1. Treatment of schizophrenia, "The expert consensus guideline series", J Clin Psychiatry, 60(Suppl 11), pp.3~80 (1999)
2. Lehman AF, "Practice guideline for the treatment of patients with schizophrenia, second edition", Am J Psychiatry, 161(2 Suppl), pp.1~56 (2004)
3. "National Institute for Mental Health in England"[URL]
4. 김원, "정신분열병 입원 환자에서의 다중약물요법: 일 대학병원에서의 1997년과 2003년의 비교", 대한정신약물학회지, 16(5), pp.390~395 (2005), 대한정신약물학회
5. Faries D, "Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics", BMC Psychiatry, 5, pp.26~ (2005)
6. Megna JL, "A study of polypharmacy with second generation antipsychotics in patients with severe and persistent mental illness", J Psychiatr Pract, 13, pp.129~137 (2007)
7. Lieberman JA, "Effectiveness of antipsychotic drugs in patients with chronic schizophrenia", N Engl J Med, 353, pp.1209~1223 (2005)
8. Shiloh R, "Atlas of psychiatric pharmacotherapy. Rev" (2000), Martin Dunitz
9. Chong MY, "Antipsychotic drug prescription for schizophrenia in East Asia: rationale for change", Psychiatry Clin Neurosci, 58, pp.61~67 (2004)
10. 김대진, "주요 정신질환의 약물치료에 대한 한국형 알고리듬 개발 (2)- 한국형 알고리듬 개발 사업내용과 기본계획, 조직구성, 알고리듬 개발의 기본원칙, 개발방법, 제한점 및 사용 시 주의점 -", 대한정신약물학회지, 13(1), pp.30~36 (2002), 대한정신약물학회
11. 안용민, "한국형 정신분열병 약물치료 알고리듬의 임상 적용 가능성(II): 적용상의 문제점 및 향후 개정 방향", 대한정신약물학회지, 17(1), pp.35~49 (2006), 대한정신약물학회
12. Rittmannsberger H, "Polypharmacy in psychiatric treatment. Patterns of psychotropic drug use in Austrian psychiatric clinics", Eur Psychiatry, 14, pp.33~40 (1999)
13. Wang PS, "Recent patterns and predictors of antipsychotic medication regimens used to treat schizophrenia and other psychotic disorders", Schizophr Bull, 26, pp.451~457 (2000)
14. Procyshyn RM, "Antipsychotic polypharmacy: a survey of discharge prescriptions from a tertiary care psychiatric institution", Can J Psychiatry, 46, pp.334~339 (2001)
15. McCue RE, "Polypharmacy in patients with schizophrenia", J Clin Psychiatry, 64, pp.984~989 (2003)
16. Sim K, "Antipsychotic polypharmacy in patients with schizophrenia: a multicentre comparative study in East Asia", Br J Clin Pharmacol, 58, pp.178~183 (2004)
17. Waring EW, "Treatment of schizophrenia with antipsychotics in combination", Can J Psychiatry, 44, pp.189~190 (1999)
18. Kennedy NB, "Procyshyn RM. Rational antipsychotic polypharmacy", Can J Clin Pharmacol, 7, pp.155~159 (2000)
19. Rhoads E, "Polypharmacy of 2 atypical antipsychotics", J Clin Psychiatry, 61, pp.678~680 (2000)
20. Taylor CG, "An open trial of risperidone augmentation of partial response to clozapine", Scizophr Res, 48, pp.155~158 (2001)
21. Ito H, "Polypharmacy and excessive dosing: psychiatrists' perceptions of antipsychotic drug prescription", Br J Psychiatry, 187, pp.243~247 (2005)
22. Stahl SM, "A critical review of atypical antipsychotic utilization: comparing monotherapy with polypharmacy and augmentation", Curr Med Chem, 11, pp.313~327 (2004)
23. Raskin S, "and risperidone: combination", augmentation treatment of refractory schizophrenia: a preliminary observation, 2000, pp.101, 334~336
24. Lerner V, "Combined use of risperidone and olanzapine in the treatment of patients with resistant schizophrenia: a preliminary case series report", Clin Neuropharmacol, 23, pp.284~286 (2000)
25. Centorrino F, "Multiple versus single antipsychotic agents for hospitalized psychiatric patients: case-control study of risks versus benefits", Am J Psychiatry, 161, pp.700~706 (2004)
26. Freudenreich O, "Antipsychotic combination therapy in schizophrenia. A review of efficacy and risks of current combinations", Acta Psychiatr Scand, 106, pp.323~330 (2002)
27. Shinfuku N, "Pharmacotherapy for schizophrenic inpatients in East Asia--changes and challenges", Int Rev Psychiatry, 20, pp.460~468 (2008)
28. Casey DE, "Effect of divalproex combined with olanzapine or risperidone in patients with an acute exacerbation of schizophrenia", Neuropsychopharmacology, 28, pp.182~192 (2003)
29. Swainston Harrison T, "Aripiprazole: a review of its use in schizophrenia and schizoaffective disorder", Drugs, 64, pp.1715~1736 (2004)
30. Andersen SE, "The prescribing pattern of a new antipsychotic: a descriptive study of aripiprazole for psychiatric in-patients", Basic Clin Pharmacol Toxicol, 103, pp.75~81 (2008)

관련 논문AI추천